Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan H Lazarus

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Vox Sanguinis|March 6, 2003
Mechanism of action of IVIG in ITPAlan H Lazarus
Expert Opinion on Biological Therapy|August 8, 2013
Monoclonal versus polyclonal anti-D in the treatment of ITPAlan H Lazarus
Journal of Clinical Immunology|April 20, 2010
Adoptive-transfer effects of intravenous immunoglobulin in autoimmunityAlan H Lazarus
Blood|December 4, 2010
IVIg conducts DC-platelet nuptialsAlan H Lazarus
Autoimmunity Reviews|February 9, 2016
Targeting FcγRs to treat antibody-dependent autoimmunityXiaojie Yu, Alan H Lazarus
Hematology. American Society of Hematology. Education Program|December 17, 2009
Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newbornDavor Brinc, Alan H Lazarus
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 3, 2003
Mechanism of action of IVIG and anti-D in ITPAlan H Lazarus, Andrew R Crow
Transfusion|February 24, 2021
Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression?Yoelys Cruz-Leal, Alan H Lazarus
Blood|May 18, 2023
TEMRA: the CD8 subset in chronic ITP?Alan H Lazarus, John W Semple
Seminars in Hematology|June 18, 2016
Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the waysideAndrew R Crow, Alan H Lazarus
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Vox Sanguinis|March 6, 2003
Mechanism of action of IVIG in ITPAlan H Lazarus
Expert Opinion on Biological Therapy|August 8, 2013
Monoclonal versus polyclonal anti-D in the treatment of ITPAlan H Lazarus
Journal of Clinical Immunology|April 20, 2010
Adoptive-transfer effects of intravenous immunoglobulin in autoimmunityAlan H Lazarus
Blood|December 4, 2010
IVIg conducts DC-platelet nuptialsAlan H Lazarus
Autoimmunity Reviews|February 9, 2016
Targeting FcγRs to treat antibody-dependent autoimmunityXiaojie Yu, Alan H Lazarus
Hematology. American Society of Hematology. Education Program|December 17, 2009
Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newbornDavor Brinc, Alan H Lazarus
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 3, 2003
Mechanism of action of IVIG and anti-D in ITPAlan H Lazarus, Andrew R Crow
Transfusion|February 24, 2021
Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression?Yoelys Cruz-Leal, Alan H Lazarus
Blood|May 18, 2023
TEMRA: the CD8 subset in chronic ITP?Alan H Lazarus, John W Semple
Seminars in Hematology|June 18, 2016
Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the waysideAndrew R Crow, Alan H Lazarus
Pageof 8